On Wednesday, June 15, 2022, from 12:05 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host the next virtual Town Hall for SARS-CoV-2 test developers. During this Town Hall, the FDA will answer technical questions about the development and validation of tests for SARS-CoV-2. Panelists include: - Timothy Stenzel, M.D., Ph.D., Director of the Office of In Vitro Diagnostics
- Toby Lowe, Associate Director for Regulatory Programs, Office of In Vitro Diagnostics
- Kristian Roth, Ph.D., Deputy Director of the Division of Microbiology Devices, Office of In Vitro Diagnostics
| | |
No comments:
Post a Comment